|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-3-16
|
|
pubmed:abstractText |
Lymph node metastasis is one of the most important adverse prognostic factors for pancreatic cancer. The aim of this study was to identify novel lymphatic metastasis-associated markers and therapeutic targets for pancreatic cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1532-1827
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1027-37
|
|
pubmed:dateRevised |
2011-5-13
|
|
pubmed:meshHeading |
pubmed-meshheading:21364590-Aged,
pubmed-meshheading:21364590-Carcinoma, Pancreatic Ductal,
pubmed-meshheading:21364590-Cell Line, Tumor,
pubmed-meshheading:21364590-Cell Movement,
pubmed-meshheading:21364590-Drug Evaluation, Preclinical,
pubmed-meshheading:21364590-Female,
pubmed-meshheading:21364590-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:21364590-Hep G2 Cells,
pubmed-meshheading:21364590-Humans,
pubmed-meshheading:21364590-Lymph Nodes,
pubmed-meshheading:21364590-Lymphatic Metastasis,
pubmed-meshheading:21364590-Male,
pubmed-meshheading:21364590-Middle Aged,
pubmed-meshheading:21364590-Neoplasm Invasiveness,
pubmed-meshheading:21364590-Pancreatic Neoplasms,
pubmed-meshheading:21364590-RNA, Small Interfering,
pubmed-meshheading:21364590-Receptors, Cytoplasmic and Nuclear,
pubmed-meshheading:21364590-Up-Regulation
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion.
|
|
pubmed:affiliation |
Samsung Biomedical Research Institute, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
